Literature DB >> 24062025

[Delayed effects of oncological therapy].

H Biersack1, G Brabant.   

Abstract

Due to therapy-associated improvements in survival rates, delayed effects of cancer are a rapidly increasing but as yet only poorly recognized problem. These delayed sequelae, which by definition occur years after the primary disease, include secondary tumors and many non-oncological internal medical problems. Little attention has so far been paid to the cardiovascular, gastrointestinal, renal and endocrinal delayed side effects and must be specifically addressed due to the often slowly progressing symptoms.

Entities:  

Mesh:

Year:  2013        PMID: 24062025     DOI: 10.1007/s00108-013-3355-z

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  42 in total

Review 1.  Clinical practice. The syndrome of inappropriate antidiuresis.

Authors:  David H Ellison; Tomas Berl
Journal:  N Engl J Med       Date:  2007-05-17       Impact factor: 91.245

Review 2.  Fractures in pediatric Ewing sarcoma.

Authors:  L M Wagner; M D Neel; A S Pappo; T E Merchant; C A Poquette; B N Rao; C Rodriguez-Galindo
Journal:  J Pediatr Hematol Oncol       Date:  2001-12       Impact factor: 1.289

3.  Incidence of thyroid hormone therapy in patients treated with sunitinib or sorafenib: a cohort study.

Authors:  Sandra Feldt; Katrin Schüssel; Renate Quinzler; Alexandra Franzmann; Sittah Czeche; Wolf-Dieter Ludwig; Martin Schulz
Journal:  Eur J Cancer       Date:  2012-02-28       Impact factor: 9.162

Review 4.  Dyslipidemia after allogeneic hematopoietic stem cell transplantation: evaluation and management.

Authors:  Michelle L Griffith; Bipin N Savani; Jeffrey B Boord
Journal:  Blood       Date:  2010-05-03       Impact factor: 22.113

5.  Long-term renal function after treatment for malignant germ-cell tumours.

Authors:  S D Fosså; N Aass; M Winderen; O P Börmer; D R Olsen
Journal:  Ann Oncol       Date:  2002-02       Impact factor: 32.976

Review 6.  Secondary cancers following allogeneic haematopoietic cell transplantation in adults.

Authors:  Navneet S Majhail
Journal:  Br J Haematol       Date:  2011-05-26       Impact factor: 6.998

7.  Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence.

Authors:  D M Green; A Hyland; M P Barcos; J A Reynolds; R J Lee; B C Hall; M A Zevon
Journal:  J Clin Oncol       Date:  2000-04       Impact factor: 44.544

8.  Prevalence of Renal Insufficiency in cancer patients and implications for anticancer drug management: the renal insufficiency and anticancer medications (IRMA) study.

Authors:  Vincent Launay-Vacher; Stéphane Oudard; Nicolas Janus; Joseph Gligorov; Xavier Pourrat; Olivier Rixe; Jean-François Morere; Philippe Beuzeboc; Gilbert Deray
Journal:  Cancer       Date:  2007-09-15       Impact factor: 6.860

Review 9.  Radiation-induced hypopituitarism after cancer therapy: who, how and when to test.

Authors:  Ken H Darzy
Journal:  Nat Clin Pract Endocrinol Metab       Date:  2009-02

10.  Risk of Late Mortality and Second Malignant Neoplasms among 5-Year Survivors of Young Adult Cancer: A Report of the Childhood, Adolescent, and Young Adult Cancer Survivors Research Program.

Authors:  Yang Zhang; Karen Goddard; John J Spinelli; Carolyn Gotay; Mary L McBride
Journal:  J Cancer Epidemiol       Date:  2012-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.